tiprankstipranks
Trending News
More News >
MoonLake Immunotherapeutics (MLTX)
NASDAQ:MLTX
US Market
Advertisement

MoonLake Immunotherapeutics (MLTX) Ownership - Who Owns MoonLake Immunotherapeutics?

Compare
363 Followers

MoonLake Immunotherapeutics (MLTX) Ownership Overview

41.86%17.69%0.21%0.68%39.56%
41.86% Insiders
0.21% Other Institutional Investors
0.68% ETFs
39.56% Public Companies and Individual Investors
The ownership structure of MoonLake Immunotherapeutics (MLTX) stock is a mix of institutional, retail, and individual investors. Approximately 18.58% of the company’s stock is owned by Institutional Investors, 41.86% is owned by Insiders, and 39.56% is owned by Public Companies and Individual Investors.
The ownership structure of MoonLake Immunotherapeutics (MLTX) stock is a mix of institutional, retail, and individual investors. Approximately 17.90% of the company’s stock is owned by Institutional Investors, 41.86% is owned by Insiders, and 0.68% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Jul 07, 2025
xxxxxxxxxxxxx
$1146565
Oct 08, 2024
xxxxxxxxxxxxx
$9186120
Oct 08, 2024
xxxxxxxxxxxxx
$100000000

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Mar 31, 2025
xxxxxxxxxxxxx
$840005
Mar 31, 2025
xxxxxxxxxxxxx
$11570502

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
19,691,695Insider31.02%1,066,896,035
3,078,577Insider4.85%166,797,302
3,009,940Insider4.74%163,078,549
1,283,609Institution2.02%69,545,936
1,263,648Institution1.99%68,464,449
1,168,000Institution1.84%63,282,240
911,480Institution1.44%49,383,986
770,822Institution1.21%41,763,136
704,819Institution1.11%38,187,093
658,083Institution1.04%35,654,937

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
1,283,609Institution2.02%69,545,936
1,263,648Institution1.99%68,464,449
1,168,000Institution1.84%63,282,240
911,480Institution1.44%49,383,986
770,822Institution1.21%41,763,136
704,819Institution1.11%38,187,093
658,083Institution1.04%35,654,937
581,762Institution0.92%31,519,865
427,579Institution0.67%23,166,230
404,694Institution0.64%21,926,321

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
68,774Institution0.11%3,246,133
47,438Institution0.07%1,850,556
31,060Institution0.05%1,682,831
29,038Institution0.05%1,554,538
23,759Institution0.04%1,287,263
22,961Institution0.04%1,244,027
21,562Institution0.03%1,017,726
21,198Institution0.03%1,078,130
19,566Institution0.03%763,270
16,753Institution0.03%820,897

FAQ

Who Owns MoonLake Immunotherapeutics (MLTX)?
According to the latest TipRanks data, approximately 0.21% of the company's stock is held by institutional investors, 41.86% is held by insiders, and 39.56% is held by retail investors.
    What percentage of MoonLake Immunotherapeutics (MLTX) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 0.21% of MoonLake Immunotherapeutics (MLTX) stock is held by institutional investors.
      What percentage of MoonLake Immunotherapeutics (MLTX) stock is held by retail investors?
      According to the latest TipRanks data, approximately 39.56% of MoonLake Immunotherapeutics (MLTX) stock is held by retail investors.
        Who owns the most shares of MoonLake Immunotherapeutics (MLTX)?
        Bvf Partners LP Il owns the most shares of MoonLake Immunotherapeutics (MLTX).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis